Search Results - "PACAK, KAREL"
-
1
New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
Published in Endocrine reviews (01-12-2017)“…A molecular biology–based taxonomy has been proposed for pheochromocytoma and paraganglioma (PPGL). Data from the Cancer Genome Atlas revealed clinically…”
Get full text
Journal Article -
2
Pheochromocytoma: The First Metabolic Endocrine Cancer
Published in Clinical cancer research (15-10-2016)“…Dysregulated metabolism is one of the key characteristics of cancer cells. The most prominent alterations are present during regulation of cell respiration,…”
Get full text
Journal Article -
3
Mitochondrial Complex II: At the Crossroads
Published in Trends in biochemical sciences (Amsterdam. Regular ed.) (01-04-2017)“…Mitochondrial complex II (CII), also called succinate dehydrogenase (SDH), is a central purveyor of the reprogramming of metabolic and respiratory adaptation…”
Get full text
Journal Article -
4
Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups
Published in Endocrine-related cancer (01-11-2019)“…In recent years, advancement in genetics has profoundly helped to gain a more comprehensive molecular, pathogenic, and prognostic picture of pheochromocytomas…”
Get full text
Journal Article -
5
Personalized Management of Pheochromocytoma and Paraganglioma
Published in Endocrine reviews (01-04-2022)“…Abstract Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape that allows their assignment to clusters based on underlying…”
Get full text
Journal Article -
6
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
Published in Current treatment options in oncology (29-08-2020)“…Opinion statement The incidence of metastatic pheochromocytoma (PHEO) and paraganglioma (PGL) may occur in as many as 35% of patients particularly with PGL and…”
Get full text
Journal Article -
7
Genomic Landscape of Pheochromocytoma and Paraganglioma
Published in Trends in cancer (01-01-2018)“…Recent comprehensive molecular analysis allowed the identification of unique molecular signatures in pheochromocytomas (PHEOs) and paragangliomas (PGLs). Here…”
Get more information
Journal Article -
8
Pheochromocytoma and paraganglioma: Diagnosis, genetics, management, and treatment
Published in Current problems in cancer (2014)Get full text
Journal Article -
9
Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging
Published in Frontiers in endocrinology (Lausanne) (27-11-2018)“…Pheochromocytomas and paragangliomas (PCCs/PGLs) are rare commonly benign neuroendocrine tumors that share pathology features and clinical behavior in many…”
Get full text
Journal Article -
10
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
Published in Journal of hypertension (01-08-2020)“…Phaeochromocytoma and paraganglioma (PPGL) are chromaffin cell tumours that require timely diagnosis because of their potentially serious cardiovascular and…”
Get full text
Journal Article -
11
Mapping of human brown adipose tissue in lean and obese young men
Published in Proceedings of the National Academy of Sciences - PNAS (08-08-2017)“…Human brown adipose tissue (BAT) can be activated to increase glucose uptake and energy expenditure, making it a potential target for treating obesity and…”
Get full text
Journal Article -
12
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
Published in The journal of clinical endocrinology and metabolism (01-06-2014)“…Objective: The aim was to formulate clinical practice guidelines for pheochromocytoma and paraganglioma (PPGL). Participants: The Task Force included a chair…”
Get full text
Journal Article -
13
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma
Published in European journal of nuclear medicine and molecular imaging (01-09-2019)“…Purpose Diverse radionuclide imaging techniques are available for the diagnosis, staging, and follow-up of phaeochromocytoma and paraganglioma (PPGL). Beyond…”
Get full text
Journal Article -
14
Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions
Published in Journal of Nuclear Medicine (01-12-2016)“…Through diagnostic imaging and peptide receptor radionuclide therapy, nuclear medicine has earned a major role in gastroenteropancreatic neuroendocrine tumors…”
Get full text
Journal Article -
15
Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine
Published in Cancers (08-10-2019)“…Pheochromocytomas and paragangliomas (PCC/PGLs) are rare, mostly catecholamine-producing neuroendocrine tumors of the adrenal gland (PCCs) or the extra-adrenal…”
Get full text
Journal Article -
16
Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma
Published in Clinical cancer research (01-09-2015)“…Patients with succinate dehydrogenase subunit B(SDHB) mutation-related pheochromocytoma/paraganglioma (PHEO/PGL) are at a higher risk for metastatic disease…”
Get full text
Journal Article -
17
Genetic Determinants of Pheochromocytoma and Paraganglioma Imaging Phenotypes
Published in Journal of Nuclear Medicine (01-05-2020)“…Parallel to the application of new PET radiopharmaceuticals for pheochromocytoma and paraganglioma (collectively named PPGLs) imaging, several studies have…”
Get full text
Journal Article -
18
Phaeochromocytoma — advances through science, collaboration and spreading the word
Published in Nature reviews. Endocrinology (01-11-2020)“…The first International Symposium on Phaeochromocytoma in 2005 was followed by considerable progress in the field, largely owing to the many collaborations and…”
Get full text
Journal Article -
19
Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia
Published in The New England journal of medicine (06-09-2012)“…Two patients with paraganglioma (one of whom also had somatostatinoma) were found to have mutations in HIF2A that altered HIF-2α turnover and led to excess…”
Get full text
Journal Article -
20
Irisin and FGF21 Are Cold-Induced Endocrine Activators of Brown Fat Function in Humans
Published in Cell metabolism (04-02-2014)“…Rediscovery of cold-activated brown adipose tissue (BAT) in humans has boosted research interest in identifying BAT activators for metabolic benefits. Of…”
Get full text
Journal Article